First Site Initiated for GMRx2 ACT
COVID-19 vaccination cuts infection risk by half in school-aged children - REACT
ZODIAC trial presented at AHA
UNEEG Medical Hyposafe System – An Exploratory Feasibility Study
GMRx2 Placebo Controlled Trial (PCT)
Imperial ranks second in the world in major university ranking
ICTU Global Launch
GMRx2 ACT1 UK update
